No overview information available.
No background information available.
用于预防和治疗钙缺乏症,如骨质疏松、手足抽搐症、骨发育不全、佝偻病以及儿童、妊娠和哺乳期妇女、绝经期妇女、老年人钙的补充。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H19990204 | 片剂(素片) | N/A | 0.25g(以钙计) | Chemical Drug | Approved | 2020/05/12 | Domestic | ||
国药准字H44024533 | 片剂(泡腾) | N/A | 0.1g(按Ca计) | Chemical Drug | Approved | 2019/09/27 | Domestic | ||
国药准字H20046363 | 片剂 | N/A | 0.1g(按钙计) | Chemical Drug | Approved | 2020/08/19 | Domestic | ||
国药准字H35021303 | 福州市兴隆制药有限公司 | N/A | N/A | 5g:50mg(按Ca计) | Chemical Drug | Approved | 2003/01/29 | Domestic | |
国药准字H20045621 | 颗粒剂 | N/A | 5g:50mg(按Ca计) | Chemical Drug | Approved | 2015/12/23 | Domestic | ||
国药准字H41024886 | 颗粒剂 | N/A | 5g:50mg(按Ca计) | Chemical Drug | Approved | 2020/07/20 | Domestic | ||
国药准字H33021799 | 颗粒剂 | N/A | 5g:50mg(按Ca计) | Chemical Drug | Approved | 2020/04/30 | Domestic | ||
国药准字H31022465 | N/A | N/A | 5g:50mg(按Ca计) | Chemical Drug | Approved | 2009/12/09 | Domestic | ||
国药准字H33022156 | 颗粒剂 | N/A | 5g:50mg(按Ca计) | Chemical Drug | Approved | 2020/06/01 | Domestic | ||
国药准字H21024455 | N/A | N/A | 5g:50mg(按Ca计) | Chemical Drug | Approved | 2004/09/06 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug